NCSA is revolutionizing precision medicine with innovative technologies and collaborative research, paving the way for personalized healthcare solutions.
India’s Commerce Secretary advocates for a shift towards quality leadership in the pharmaceutical sector, aiming to enhance exports and industry standards.
Eli Lilly has entered a $2.75 billion partnership with InSilico Medicine to enhance AI-driven drug discovery, promising rapid advancements in pharmaceuticals.
A recent webinar addressed critical challenges in tuberculosis care in India, highlighting the need for innovative strategies and stakeholder collaboration.